Belantamab mafodotin monotherapy for relapsed or refractory multiple myeloma: a real-world observational study in the United States

Affiliations

• ¹ Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY. [email protected].
• ² Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY.
• ³ Division of Medical Oncology, Washington University School of Medicine, St. Louis, MO.
• ⁴ Hematology Department, University Hospital of Leon, Leon.
• ⁵ Department of Hematology, Catholic University of Leuven, Leuven.
• ⁶ Value, Evidence and Outcomes, GSK, Upper Providence, PA.
• ⁷ Global Medical Affairs, GSK, Zug.
• ⁸ Real World Study Delivery, GSK, Stevenage.
• ⁹ Real World Data Strategy and Partnerships, Value, Evidence and Outcomes, GSK, Collegeville, PA.
• ¹⁰ Groupe d'Analyse, Ltee., Montreal, Quebec.
• ¹¹ Analysis Group, Inc., Boston, MA.
• ¹² IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seragnoli", Universita degli Studi di Bologna, Bologna.
• ¹³ Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.